High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaJ. A. Child, Peter J. Selby, Gareth J. Morgan et al.|New England Journal of Medicine|2003Cited by 1.8k
The genetic architecture of multiple myelomaGareth J. Morgan, Faith E. Davies, Brian A. Walker|Nature reviews. Cancer|2012Cited by 919
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaFaith E. Davies, Kenneth C. Anderson, Noopur Raje et al.|Blood|2001Cited by 905
International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewRafaël Fonseca, Hervé Avet‐Loiseau, Faith E. Davies et al.|Leukemia|2009Cited by 877
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialGareth J. Morgan, J. Anthony Child, Faith E. Davies et al.|The Lancet|2010Cited by 571